ClinicalTrials.gg
RecruitingNCT04927156EVIDENCEUpdated Sep 18, 2025

Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform

An observational study in Intracranial Aneurysm, Brain Arterial Disease and Acute Ischemic Stroke, sponsored by Balt Extrusion. Recruiting at 12 sites in 3 countries. Open to participants aged 2 Years and older. Per ClinicalTrials.gov, last updated 2025-09-18.

Sponsored by Balt Extrusion · Observational

How we know

From the registry’s dates

  • Started Jul 2021; still recruiting 5 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
10,000
Ages
2 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 66 studies in Intracranial Aneurysm with a site in France — 19 open to participants now, 26 under way, 1 of them phase 3. Intracranial Aneurysm · France.

Planned enrollment
3rd of 43
10,000 · median 206
Started
2021
with 3 others
Observational
43 of 66
10 open now
Primary completion
2041-06
later than 25 of 25 live
Registered
49th of 66
by date
Lead sponsor
3 of 66
Balt Extrusion

Among the 66 studies in Intracranial Aneurysm with a site in France, this one is the 3rd largest by planned enrollment of the 43 observational ones that give a count, is one of 4 that started in 2021, is one of 43 observational ones, reaches primary completion later than 25 of the 25 other live ones, and was the 49th registered.

Intracranial Aneurysm

419 studies on the registry are indexed under Intracranial Aneurysm; 118 are open to participants now.

Browse Intracranial Aneurysm studies →

Open to participants now

19 of the 66 studies in Intracranial Aneurysm with a site in France are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 84 Intracranial Aneurysm studies recruiting now, 50 (60%) set no upper age limit and 15 (18%) stop at 75 or younger; 16 take children under 18; 6 take healthy volunteers.

This study: 2 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 66 studies in Intracranial Aneurysm with a site in France, or all of them as a file.
02

Study summary

BALT has designed an electronic platform to continue collecting clinical data as part of the post-marketing clinical follow-up of its devices.

This platform is purely exploratory, without hierarchical order of the objectives and associated outcomes.

03

Conditions studied

  • Intracranial Aneurysm
  • Brain Arterial Disease
  • Acute Ischemic Stroke
  • Peripheral Vascular Diseases
  • AVM - Cerebral Arteriovenous Malformation
  • AVM
  • Fistulas Arteriovenous

Keywords

  • catheter
  • guidewire
04

Who can participate

Ages eligible
2 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study population will include the BALT medical devices under consideration used in their respective indications for use during interventions performed at the participating sites.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Provision of a signed, written and dated or non-opposition (where applicable)

Exclusion criteria

Exclusion Criteria

  • Device(s) used in multiple procedures (two, or more, pathologies treated during the same procedure)
  • of each device as described in the instructions for use.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
10,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • BALT medical devices

    Device: BALT medical devices

Interventions

  • DeviceBALT medical devices

    Includes, but is not limited to, the following: * Access devices * Aneurysm treatment devices * Ischemic Stroke and peripheral occlusive diseases treatment devices * Arterio-Venous Malformations/fistulas treatment devices

06

What researchers measure

Primary outcomes

  1. Rate of occurrence of device-specific safety indicator(s).

    Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.

    Time frame: From the procedure to 12 months post-procedure depending on the device family.

  2. Rate of devices achieving its intended use.

    Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.

    Time frame: From the procedure to 12 months post-procedure depending on the device family.

  3. Rate of devices achieving its specific performance indicator(s).

    Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.

    Time frame: From the procedure to 12 months post-procedure depending on the device family.

  4. Rate of devices in each category of the usability scale (Likert-type scale) for each usability indicator

    Qualitative measurement of usability for each usability indicator (i.e., good, well adapted, fairly adapted, bad). Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.

    Time frame: From the procedure to 12 months post-procedure depending on the device family.

07

Study locations

10 of 12 sites recruiting
08

References and documents

Related links

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2021 (actual). Primary completion is estimated for Jun 2041, 239 months after the start.

Of 105 observational studies under Intracranial Aneurysm, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 36 and three quarters within 145. This study's planned 239 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 9, 2021
First posted
Jun 15, 2021
StartActual
Jul 12, 2021
Primary completionEst.
Jun 2041
CompletionEst.
Oct 2041
Last update
Sep 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04927156
Lead sponsor
Balt Extrusion
Responsible party
Sponsor
First posted
Jun 15, 2021
Start date
Jul 12, 2021
Primary completion
Jun 2041 (estimated)
Completion
Oct 2041 (estimated)
Last update
Sep 18, 2025

Study contacts

Clinical Affairs Department
Contact
Evidence@baltgroup.com
+33 1 39 89 46 41

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion